{"PubmedArticle": [{"MedlineCitation": {"InvestigatorList": [], "SpaceFlightMission": [], "CitationSubset": ["IM"], "KeywordList": [], "GeneralNote": [], "OtherAbstract": [], "OtherID": [], "PMID": "11159012", "DateCompleted": {"Year": "2001", "Month": "03", "Day": "08"}, "DateRevised": {"Year": "2022", "Month": "02", "Day": "23"}, "Article": {"Language": ["eng"], "ELocationID": [], "ArticleDate": [], "Journal": {"ISSN": "1040-0605", "JournalIssue": {"Volume": "280", "Issue": "2", "PubDate": {"Year": "2001", "Month": "Feb"}}, "Title": "American journal of physiology. Lung cellular and molecular physiology", "ISOAbbreviation": "Am J Physiol Lung Cell Mol Physiol"}, "ArticleTitle": "Toll-like receptor 4 mediates ozone-induced murine lung hyperpermeability via inducible nitric oxide synthase.", "Pagination": {"StartPage": "L326", "EndPage": "L333", "MedlinePgn": "L326-33"}, "Abstract": {"AbstractText": ["We tested the hypotheses that 1) inducible nitric oxide synthase (iNOS) mediates ozone (O3)-induced lung hyperpermeability and 2) mRNA levels of the gene for iNOS (Nos2) are modulated by Toll-like receptor 4 (Tlr4) during O3 exposure. Pretreatment of O3-susceptible C57BL/6J mice with a specific inhibitor of total NOS (N(G)-monomethyl-L-arginine) significantly decreased the mean lavageable protein concentration (a marker of lung permeability) induced by O3 (0.3 parts/million for 72 h) compared with vehicle control mice. Furthermore, lavageable protein in C57BL/B6 mice with targeted disruption of Nos2 [Nos2(-/-)] was 50% less than the protein in wild-type [Nos2(+/+)] mice after O3. To determine whether Tlr4 modulates Nos2 mRNA levels, we studied C3H/HeJ (HeJ) and C3H/HeOuJ mice that differ only at a missense mutation in Tlr4 that confers resistance to O3-induced lung hyperpermeability in the HeJ strain. Nos2 and Tlr4 mRNA levels were significantly reduced and correlated in resistant HeJ mice after O3 relative to those in susceptible C3H/HeOuJ mice. Together, the results are consistent with an important role for iNOS in O3-induced lung hyperpermeability and suggest that Nos2 mRNA levels are mediated through Tlr4."]}, "AuthorList": [{"AffiliationInfo": [{"Identifier": [], "Affiliation": "Department of Environmental Health Sciences, The Johns Hopkins University School of Public Health, Baltimore, Maryland 21205, USA. skleeber@jhsph.edu"}], "Identifier": [], "LastName": "Kleeberger", "ForeName": "S R", "Initials": "SR"}, {"AffiliationInfo": [], "Identifier": [], "LastName": "Reddy", "ForeName": "S P", "Initials": "SP"}, {"AffiliationInfo": [], "Identifier": [], "LastName": "Zhang", "ForeName": "L Y", "Initials": "LY"}, {"AffiliationInfo": [], "Identifier": [], "LastName": "Cho", "ForeName": "H Y", "Initials": "HY"}, {"AffiliationInfo": [], "Identifier": [], "LastName": "Jedlicka", "ForeName": "A E", "Initials": "AE"}], "GrantList": [{"GrantID": "ES-03819", "Acronym": "ES", "Agency": "NIEHS NIH HHS", "Country": "United States"}, {"GrantID": "ES-09606", "Acronym": "ES", "Agency": "NIEHS NIH HHS", "Country": "United States"}, {"GrantID": "R01-HL-57142", "Acronym": "HL", "Agency": "NHLBI NIH HHS", "Country": "United States"}, {"GrantID": "R29-HL-58122", "Acronym": "HL", "Agency": "NHLBI NIH HHS", "Country": "United States"}], "PublicationTypeList": ["Journal Article", "Research Support, U.S. Gov't, Non-P.H.S.", "Research Support, U.S. Gov't, P.H.S."]}, "MedlineJournalInfo": {"Country": "United States", "MedlineTA": "Am J Physiol Lung Cell Mol Physiol", "NlmUniqueID": "100901229", "ISSNLinking": "1040-0605"}, "ChemicalList": [{"RegistryNumber": "0", "NameOfSubstance": "Drosophila Proteins"}, {"RegistryNumber": "0", "NameOfSubstance": "Enzyme Inhibitors"}, {"RegistryNumber": "0", "NameOfSubstance": "Membrane Glycoproteins"}, {"RegistryNumber": "0", "NameOfSubstance": "Proteins"}, {"RegistryNumber": "0", "NameOfSubstance": "RNA, Messenger"}, {"RegistryNumber": "0", "NameOfSubstance": "Receptors, Cell Surface"}, {"RegistryNumber": "0", "NameOfSubstance": "Toll-Like Receptor 4"}, {"RegistryNumber": "0", "NameOfSubstance": "Toll-Like Receptors"}, {"RegistryNumber": "27JT06E6GR", "NameOfSubstance": "omega-N-Methylarginine"}, {"RegistryNumber": "66H7ZZK23N", "NameOfSubstance": "Ozone"}, {"RegistryNumber": "EC 1.14.13.39", "NameOfSubstance": "Nitric Oxide Synthase"}, {"RegistryNumber": "EC 1.14.13.39", "NameOfSubstance": "Nitric Oxide Synthase Type II"}, {"RegistryNumber": "EC 1.14.13.39", "NameOfSubstance": "Nos2 protein, mouse"}], "MeshHeadingList": [{"QualifierName": [], "DescriptorName": "Administration, Inhalation"}, {"QualifierName": [], "DescriptorName": "Animals"}, {"QualifierName": ["chemistry", "cytology"], "DescriptorName": "Bronchoalveolar Lavage Fluid"}, {"QualifierName": ["drug effects"], "DescriptorName": "Capillary Permeability"}, {"QualifierName": [], "DescriptorName": "Cell Count"}, {"QualifierName": [], "DescriptorName": "Drosophila Proteins"}, {"QualifierName": ["administration & dosage"], "DescriptorName": "Enzyme Inhibitors"}, {"QualifierName": ["cytology"], "DescriptorName": "Epithelial Cells"}, {"QualifierName": [], "DescriptorName": "Injections, Intraperitoneal"}, {"QualifierName": ["blood supply", "drug effects", "metabolism"], "DescriptorName": "Lung"}, {"QualifierName": ["cytology"], "DescriptorName": "Macrophages, Alveolar"}, {"QualifierName": [], "DescriptorName": "Male"}, {"QualifierName": ["genetics", "metabolism"], "DescriptorName": "Membrane Glycoproteins"}, {"QualifierName": [], "DescriptorName": "Mice"}, {"QualifierName": [], "DescriptorName": "Mice, Inbred Strains"}, {"QualifierName": [], "DescriptorName": "Mice, Knockout"}, {"QualifierName": ["cytology"], "DescriptorName": "Neutrophils"}, {"QualifierName": ["antagonists & inhibitors", "genetics", "metabolism"], "DescriptorName": "Nitric Oxide Synthase"}, {"QualifierName": [], "DescriptorName": "Nitric Oxide Synthase Type II"}, {"QualifierName": ["administration & dosage", "toxicity"], "DescriptorName": "Ozone"}, {"QualifierName": ["analysis"], "DescriptorName": "Proteins"}, {"QualifierName": ["metabolism"], "DescriptorName": "RNA, Messenger"}, {"QualifierName": ["genetics", "metabolism"], "DescriptorName": "Receptors, Cell Surface"}, {"QualifierName": [], "DescriptorName": "Toll-Like Receptor 4"}, {"QualifierName": [], "DescriptorName": "Toll-Like Receptors"}, {"QualifierName": ["administration & dosage"], "DescriptorName": "omega-N-Methylarginine"}]}, "PubmedData": {"ReferenceList": [], "History": [{"Year": "2001", "Month": "2", "Day": "13", "Hour": "11", "Minute": "0"}, {"Year": "2001", "Month": "3", "Day": "10", "Hour": "10", "Minute": "1"}, {"Year": "2001", "Month": "2", "Day": "13", "Hour": "11", "Minute": "0"}], "PublicationStatus": "ppublish", "ArticleIdList": ["11159012", "10.1152/ajplung.2001.280.2.L326"]}}], "PubmedBookArticle": []}